Cytopathologic and histopathologic characteristics of SMARCB1 deficient neoplasm and correlation with molecular and immunohistochemical findings
{{output}}
Introduction: SMARCB1 deficient neoplasm is an aggressive and heterogeneous group of neoplasms. The morphology of the neoplasm is highly variable. Recent clinical trials show that targeted therapy with EHZ2 inhibitor tazemetostat... ...
